Nano Dimension: The Next Big Thing for 3D Bioprinting

Nano Dimension (TASE:NNDM, NASDAQ:NNDM) recently announced it has filed a patent application with the U.S. Patent and Trademark Office for the 3D printing of stem cells.
The patent covers several of aspects related to the 3D printing of human tissues and organs by using stem cells and inkjet technology. For instance, it addresses the possibility of converting MRI and CT scans and images into a 3D structure of organs that can be printed using bioink materials. The patent application also touches upon the use of proprietary software whose algorithm analyzes the 3D structure of a tissue or organ, converting it into two dimensional sections.
In an interview Nano Dimension CEO, Amit Dror, discussed the process:
https://www.youtube.com/watch?feature=youtu.be&v=3eEI_gnlFbg&app=desktop
Connect with Nano Dimension (TASE:NNDM,NASDAQ:NNDM) to receive an Investor Presentation.